What is the current price of BRN.AX stock?

BRN.AX stock is trading pre-market at **A$0.14** on 21 Mar 2026 with a one-day change of **-6.90%** and volume **3,578,534** shares. Prices can move quickly on news or earnings.

How does the Lockheed collaboration affect BRN.AX stock?

The ForwardEdge/Lockheed tie provides a clear commercial pathway into defence edge-AI, which can de-risk integration and support higher-margin ASIC business. Market impact depends on contract size and timing, so near-term stock moves may be muted.

What is Meyka AI’s forecast for BRN.AX stock?

Meyka AI's forecast model projects a 1-year price of **A$0.14** and a 3-year price of **A$0.05** for BRN.AX stock, implying modest near-term upside and substantial longer-term downside if revenue fails to scale.

What are the main risks for BRN.AX stock investors?

Primary risks include high valuation versus revenue, continued operating losses, potential dilution, thin liquidity, and dependency on securing scaled contracts. Execution delays in defence or commercial deployments would pressure BRN.AX stock.

AU Stocks

Lockheed tie lifts BRN.AX BrainChip ASX A$0.14 pre-market Mar 2026: edge AI

ByHuzaifa Zahoor March 21, 2026March 21, 2026

A strategic collaboration with ForwardEdge/Lockheed Martin is the key catalyst for BRN.AX stock as we open pre-market on 21 Mar 2026. BrainChip Holdings Ltd (BRN.AX) trades at A$0.14, down 6.90% from the prior close, with volume at 3,578,534 shares. We examine how the defence tie-up, current financials and technicals reshape the ASX-listed neuromorphic AI specialist’s near-term outlook and trading risks.